Literature DB >> 11429587

T cells and tumours.

D Pardoll.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429587     DOI: 10.1038/35082676

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  17 in total

1.  Quantitative trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulations.

Authors:  M A Hall; P J Norman; B Thiel; H Tiwari; A Peiffer; R W Vaughan; S Prescott; M Leppert; N J Schork; J S Lanchbury
Journal:  Am J Hum Genet       Date:  2002-04-09       Impact factor: 11.025

2.  Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen.

Authors:  Amy D Higgins; Marianne A Mihalyo; Adam J Adler
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

Review 3.  Kleemeier Award Lecture 2008--the canary in the coal mine: telomeres and human healthspan.

Authors:  Rita B Effros
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-19       Impact factor: 6.053

4.  MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells.

Authors:  Elena Catalán; Seyma Charni; Paula Jaime; Juan Ignacio Aguiló; José Antonio Enríquez; Javier Naval; Julián Pardo; Martín Villalba; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

5.  Carboxymethylpachymaran enhances immunologic function of dendritic cells cultured in two kinds of hepatoma carcinoma cell line's supernatant via nuclear factor κ B/Rel pathway.

Authors:  Zhuo Chen; Bin Yu; Xian-Lin Wu; Cong-Qi Dai; Guo-Qiang Qian; Jian-Zhong Yu; Hai-Bin He; Zhi-Xin Wang; Jun Hou; Xiao-Yin Chen
Journal:  Chin J Integr Med       Date:  2012-04-02       Impact factor: 1.978

Review 6.  Considerations for successful cancer immunotherapy in aged hosts.

Authors:  V Hurez; Á S Padrón; R S Svatek; T J Curiel
Journal:  Clin Exp Immunol       Date:  2016-11-07       Impact factor: 4.330

Review 7.  Tregs and rethinking cancer immunotherapy.

Authors:  Tyler J Curiel
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

Authors:  David H Munn; Madhav D Sharma; Deyan Hou; Babak Baban; Jeffrey R Lee; Scott J Antonia; Jane L Messina; Phillip Chandler; Pandelakis A Koni; Andrew L Mellor
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

9.  CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice.

Authors:  Susan E Erdman; Theofilos Poutahidis; Michal Tomczak; Arlin B Rogers; Kathleen Cormier; Benjamin Plank; Bruce H Horwitz; James G Fox
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

10.  CXCL10 expression and prognostic significance in stage II and III colorectal cancer.

Authors:  Zheng Jiang; Ye Xu; Sanjun Cai
Journal:  Mol Biol Rep       Date:  2009-10-10       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.